Open Label Extension Study to Protocol C2/13/DR-6MP-02 (OLE)

This study has been withdrawn prior to enrollment.
(Sponsor withdrew support for study due to reorganization and project prioritization)
Sponsor:
Information provided by (Responsible Party):
Teva GTC
ClinicalTrials.gov Identifier:
NCT01433432
First received: September 12, 2011
Last updated: March 5, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: August 2012
  Estimated Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)